Mutations in the gene encoding the isocitrate dehydrogenase (IDH) enzyme involved in the tricarboxylic acid (TCA) cycle results in the production of the oncometabolite 2-hydroxyglutarate (2HG) and has been identified in ~6% of AML patients [31]. The gene discussed is IDH3A; the disease is acute myeloid leukemia.